Breaking News Instant updates and real-time market news.

DOOR

Masonite

$62.63

-0.385 (-0.61%)

16:39
11/04/19
11/04
16:39
11/04/19
16:39

Masonite backs FY19 adjusted EPS view $3.30-$3.90, consensus $3.62

The full-year 2019 outlook remains consistent with the update provided on the company's second quarter earnings call. That outlook included net sales growth in the range of zero to two percent, Adjusted EBITDA of $275 million to $295 million and diluted adjusted earnings per share* of $3.30 to $3.90.

  • 05

    Nov

  • 05

    Nov

DOOR Masonite
$62.63

-0.385 (-0.61%)

12/19/18
WEDB
12/19/18
NO CHANGE
Target $50
WEDB
Neutral
Masonite price target lowered to $50 from $60 at Wedbush
Wedbush analyst Jay McCanless lowered his price target for Masonite (DOOR) to $50 from $60 and reiterated a Neutral rating on the shares. The analyst cited the pending departure of long-time CEO Fred Lynch and the potential industry disruption from litigation between privately held Steve's and Sons and Jeld-Wen (JELD). McCanless is concerned Masonite may mark time until the CEO successor is announced sometime in early 2019.
02/01/19
RILY
02/01/19
DOWNGRADE
Target $56
RILY
Neutral
Masonite downgraded to Neutral from Buy at B. Riley FBR
B. Riley FBR analyst Alex Rygiel downgraded Masonite International to Neutral and lowered his price target for the shares to $56 from $66. The analyst cites the company's negative Q4 preannouncement for his reduced estimates and lowered rating.
03/15/19
GHSC
03/15/19
INITIATION
Target $61
GHSC
Buy
Masonite initiated with a Buy at Seaport Global
Seaport Global analyst Reuben Garner initiated Masonite with a Buy rating and a price target of $61, saying there are "company specific drivers" for the company beyond his optimistic outlook on the U.S. housing market. The analyst cites the company as being "most exposed" to the residential "replace and remodel" segment of the industry, its focus on "increasing average unit price through innovation," and its control over margin expansion. Garner further contends that the valuation hit on Masonite over the past few years are "not commensurate" with the company's fundamental improvements.
05/03/19
JPMS
05/03/19
NO CHANGE
Target $71
JPMS
Overweight
Masonite price target raised to $71 from $66 at JPMorgan
JPMorgan analyst Michael Rehaut raised his price target on Overweight-rated Masonite to $71 from $66 following this week's Q1 results. The analyst says the company's restructuring plan is happening on an accelerating timeline.

TODAY'S FREE FLY STORIES

ETN

Eaton

$93.38

0.69 (0.74%)

06:35
12/12/19
12/12
06:35
12/12/19
06:35
Initiation
Eaton initiated  »

Eaton initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAL

Western Alliance

$54.03

-0.15 (-0.28%)

06:35
12/12/19
12/12
06:35
12/12/19
06:35
Conference/Events
Western Alliance management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

PLCE

Children's Place

$54.36

-16.31 (-23.08%)

06:35
12/12/19
12/12
06:35
12/12/19
06:35
Downgrade
Children's Place rating change  »

Children's Place…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSC

Norfolk Southern

$191.07

2.43 (1.29%)

06:34
12/12/19
12/12
06:34
12/12/19
06:34
Conference/Events
Norfolk Southern management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

EMR

Emerson

$75.75

1.21 (1.62%)

06:33
12/12/19
12/12
06:33
12/12/19
06:33
Initiation
Emerson initiated  »

Emerson initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VERU

Veru

$2.47

0.17 (7.39%)

06:33
12/12/19
12/12
06:33
12/12/19
06:33
Earnings
Veru reports Q4 EPS (5c), consensus (5c) »

Reports Q4 revenue $8.7M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TRKNY

Turk Telekom

$0.00

(0.00%)

06:31
12/12/19
12/12
06:31
12/12/19
06:31
Downgrade
Turk Telekom rating change  »

Turk Telekom downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKZOY

AkzoNobel

$0.00

(0.00%)

06:30
12/12/19
12/12
06:30
12/12/19
06:30
Upgrade
AkzoNobel rating change  »

AkzoNobel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGNX

Cognex

$52.45

1.51 (2.96%)

06:30
12/12/19
12/12
06:30
12/12/19
06:30
Initiation
Cognex initiated  »

Cognex initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COLD

Americold Realty Trust

$35.03

-0.66 (-1.85%)

, INVH

Invitation Homes

$29.46

-0.42 (-1.41%)

06:29
12/12/19
12/12
06:29
12/12/19
06:29
Recommendations
Americold Realty Trust, Invitation Homes analyst commentary  »

Citi adds Americold…

COLD

Americold Realty Trust

$35.03

-0.66 (-1.85%)

INVH

Invitation Homes

$29.46

-0.42 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSG

Wanda Sports

$2.82

-0.01 (-0.35%)

06:28
12/12/19
12/12
06:28
12/12/19
06:28
Downgrade
Wanda Sports rating change  »

Wanda Sports downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GKOS

Glaukos

$57.32

-1.895 (-3.20%)

, SPNE

SeaSpine

$12.00

-0.58 (-4.61%)

06:27
12/12/19
12/12
06:27
12/12/19
06:27
Downgrade
Glaukos, SeaSpine, Merit Medical, Medtronic, Teleflex rating change  »

SeaSpine, Glaukos…

GKOS

Glaukos

$57.32

-1.895 (-3.20%)

SPNE

SeaSpine

$12.00

-0.58 (-4.61%)

MMSI

Merit Medical

$29.99

0.69 (2.35%)

MDT

Medtronic

$111.67

0.62 (0.56%)

TFX

Teleflex

$354.93

1.18 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

REG

Regency Centers

$62.65

-1.6 (-2.49%)

06:27
12/12/19
12/12
06:27
12/12/19
06:27
Downgrade
Regency Centers rating change  »

Regency Centers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WRI

Weingarten Realty

$31.03

-0.41 (-1.30%)

06:26
12/12/19
12/12
06:26
12/12/19
06:26
Upgrade
Weingarten Realty rating change  »

Weingarten Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLCE

Children's Place

$54.36

-16.31 (-23.08%)

06:25
12/12/19
12/12
06:25
12/12/19
06:25
Downgrade
Children's Place rating change  »

Children's Place…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

O

Realty Income

$74.56

-1.08 (-1.43%)

06:24
12/12/19
12/12
06:24
12/12/19
06:24
Upgrade
Realty Income rating change  »

Realty Income upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADC

Agree Realty

$70.90

-1.34 (-1.85%)

06:23
12/12/19
12/12
06:23
12/12/19
06:23
Upgrade
Agree Realty rating change  »

Agree Realty upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICI

VICI Properties

$24.70

-0.17 (-0.68%)

06:22
12/12/19
12/12
06:22
12/12/19
06:22
Upgrade
VICI Properties rating change  »

VICI Properties upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDR

UDR, Inc.

$46.80

-0.95 (-1.99%)

06:21
12/12/19
12/12
06:21
12/12/19
06:21
Upgrade
UDR, Inc. rating change  »

UDR, Inc. upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

DOC

Physicians Realty Trust

$18.64

-0.35 (-1.84%)

06:19
12/12/19
12/12
06:19
12/12/19
06:19
Upgrade
Physicians Realty Trust rating change  »

Physicians Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

HR

Healthcare Realty Trust

$32.85

-0.59 (-1.76%)

06:18
12/12/19
12/12
06:18
12/12/19
06:18
Upgrade
Healthcare Realty Trust rating change  »

Healthcare Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,749.00

9.85 (0.57%)

06:18
12/12/19
12/12
06:18
12/12/19
06:18
Periodicals
Amazon sells children's smartwatches that are 'so easy to hack,' BI reports »

Amazon sells…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBF

SoftBank

$0.00

(0.00%)

06:16
12/12/19
12/12
06:16
12/12/19
06:16
Periodicals
SoftBank Vision Fund managing partner to leave company, Business Insider says »

Praveen Akkiraju, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$113.26

-0.32 (-0.28%)

06:15
12/12/19
12/12
06:15
12/12/19
06:15
Recommendations
Neurocrine analyst commentary  »

Neurocrine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXAS

Exact Sciences

$85.16

-0.25 (-0.29%)

06:13
12/12/19
12/12
06:13
12/12/19
06:13
Hot Stocks
Exact Sciences announces new data supporting Oncotype DX Breast Recurrence Score »

Exact Sciences announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.